KR100271907B1 - A production method for sulfamide - Google Patents

A production method for sulfamide Download PDF

Info

Publication number
KR100271907B1
KR100271907B1 KR1019930002367A KR930002367A KR100271907B1 KR 100271907 B1 KR100271907 B1 KR 100271907B1 KR 1019930002367 A KR1019930002367 A KR 1019930002367A KR 930002367 A KR930002367 A KR 930002367A KR 100271907 B1 KR100271907 B1 KR 100271907B1
Authority
KR
South Korea
Prior art keywords
group
sulfamide
rings
alkyl
alcohol
Prior art date
Application number
KR1019930002367A
Other languages
Korean (ko)
Other versions
KR930017872A (en
Inventor
유지 센도
마고또 기이
야스히로 니시다니
다다시 이리에
유다까 니시노
Original Assignee
시오노 요시히코
시오노기 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4221767A external-priority patent/JP2542773B2/en
Application filed by 시오노 요시히코, 시오노기 세이야쿠 가부시키가이샤 filed Critical 시오노 요시히코
Publication of KR930017872A publication Critical patent/KR930017872A/en
Application granted granted Critical
Publication of KR100271907B1 publication Critical patent/KR100271907B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/04Diamides of sulfuric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L63/00Compositions of epoxy resins; Compositions of derivatives of epoxy resins

Abstract

본 발명에 의한 술파미드의 제조방법은 옥시카르보닐술파미드 화합물과 알코을을 아조디카르복실산 유도체와 3가 인 화합물의 존재하에서, 반응시키는 단계로 구성된다.The method for producing sulfamide according to the present invention comprises the step of reacting an oxycarbonylsulfamide compound and an alcohol in the presence of an azodicarboxylic acid derivative and a trivalent phosphorus compound.

본 발명의 한 실시형태에 있어서, 상기 술파미드는 하기 일반식(I)로, 상기 알코올은 하기 일반식(II)로, 상기 옥시카르보닐 술파미드 화합물은 하기 구조식(III)으로 각각 표시되는 것을 특징으로 하는 술파미드의 제조방법.In one embodiment of the present invention, the sulfamide is represented by the following general formula (I), the alcohol is represented by the following general formula (II), and the oxycarbonyl sulfamide compound is represented by the following structural formula (III) Method for producing a sulfamide, characterized in that.

R3NHSO2NR1R2(I)R 3 NHSO 2 NR 1 R 2 (I)

[단, 상기 식중 Rl및 R2는 각각 수소, 알킬, 시클로알킬, 알케닐, 알키닐, 아르알킬, 아릴, 헤테로시클릭 기 및 이들 헤테로시클릭 기로 치환된 알킬기 중에서 독립적으로 선택되는 기이고; R3는 알킬, 알케닐, 알키닐, 아르알킬, 헤테로시클릭 기, 헤테로시클릭 기로 치환된 알킬 및 피롤리디닐 메틸 중에서 선택되는 기이며(상기한 헤테로시클릭 기는 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바페넴 환 중에서 선택되는 것임);[Wherein R 1 and R 2 are each independently selected from hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, aryl, heterocyclic group and alkyl group substituted with these heterocyclic groups; ; R 3 is a group selected from alkyl, alkenyl, alkynyl, aralkyl, heterocyclic group, alkyl substituted with heterocyclic group and pyrrolidinyl methyl (the heterocyclic groups described above are pyranosyl, furanosyl, pipepe Lidinyl, pyrrolidinyl, azetidinone ring, cefem ring, penem ring and carbapenem ring);

R3OH (II)R 3 OH (II)

(단, 상기 식중 R3는 상기에서 정의한 바와 같음);Provided that R 3 is as defined above;

R4OOC-NHSO2NR1R2(III)R 4 OOC-NHSO 2 NR 1 R 2 (III)

(단, 상기 식중 Rl및 R2는 상기에서 정의된 바와 같고, R4는 카르복시 보호기 임)으로 각각 나타내어 진다.Wherein R 1 and R 2 are as defined above and R 4 is a carboxy protecting group.

Description

[발명의 명칭][Name of invention]

술파미드의 제조방법Method for producing sulfamide

[발명의 상세한 설명]Detailed description of the invention

본 발명은 약물, 동식물용 의약품, 폴리머 및 입체 이성질체 알코올 화합물을 제조하는데 유용한 술파미드류의 제조방법에 관한 것이다.The present invention relates to a method for producing sulfamides useful for producing drugs, animal and plant medicines, polymers and stereoisomeric alcohol compounds.

일반적으로, 알코올로부터 술파미드류를 제조하는데 있어서는 다음과 같은 4 내지 5단계가 포함된다 : 알코올을 할로겐 화합물 또는 술포닐에스테르로 전환시키고, 할로겐 또는 술포닐 에스테르 기를 아지도 기로 치환하여 아지드 화합물을 얻은 후, 아지도 기를 아미노 기로 환원시킨다. 또 한편으로는, 알코올을 할로겐 화합물 또는 술포닐 에스테르로 전환시키고, 할로겐 또는 술포닐 에스테르 기를 프탈이미도 기로 치환한 후, 프탈이미도 기중의 프탈로일 기를 히드라진을 사용하여 제거하여 아미노 기를 얻는다. 상기한 방법들중 어느 한 방법으로 제조된 아민을 술파모일화제와 반응시키면 술파미드를 얻을 수 있다. 생성된 술파미드는 필요시, 탈보호 시킨다.In general, the preparation of sulfamides from alcohols involves four to five steps: converting the alcohol to a halogen compound or sulfonyl ester and substituting a halogen or sulfonyl ester group with an azido group to convert the azide compound. After obtaining, the azido group is reduced to an amino group. On the other hand, the alcohol is converted into a halogen compound or sulfonyl ester, the halogen or sulfonyl ester group is replaced with a phthalimido group, and then the phthaloyl group in the phthalimido group is removed using hydrazine to obtain an amino group. Sulfamid can be obtained by reacting an amine prepared by any of the above methods with a sulfamoylating agent. The resulting sulfamide is deprotected if necessary.

그러나, 이들 방법은 다음과 같은 문제점, 즉 상기한 공정단계들이 복잡하고; 반응시키는 화합물이 그 분자내에 부반응을 일으킬 수 있는 작용 기를 갖는 경우에는, 각 반응단계에서 반응조건에 합당한 보호 기를 도입하거나 제거해야할 필요가 있고; 폭발성 및 독성이 큰, 아지드 화합물 및 히드라진을 필요로 하는 문제점을 갖고 있다.However, these methods have the following problems, that is, the process steps described above are complicated; When the compound to be reacted has a functional group capable of causing a side reaction in the molecule, it is necessary to introduce or remove a protecting group appropriate to the reaction conditions in each reaction step; There is a problem of requiring azide compounds and hydrazine, which are highly explosive and toxic.

본 발명의 술파미드를 제조하는 방법은, 알코올과 옥시카르보닐술파미드 화합물을, 3가 인 화합물 및 아조디카르복실산 유도체의 존재하에서 반응시키는 단계로 이루어진다.The method for producing the sulfamide of the present invention comprises reacting an alcohol with an oxycarbonylsulphamide compound in the presence of a trivalent phosphorus compound and an azodicarboxylic acid derivative.

본 발명의 한 실시형태에 있어서, 술파미드는 다음 일반식(I)로 표시되고, 알코올은 다음 일반식(II)로 표시되며, 옥시카르보닐술파미드 화합물은 다음 일반식(III)으로 표시된다 :In one embodiment of the invention, the sulfamide is represented by the following general formula (I), the alcohol is represented by the following general formula (II), and the oxycarbonylsulfamide compound is represented by the following general formula (III) :

R3NHSO2NR1R2(I)R 3 NHSO 2 NR 1 R 2 (I)

[여기에서, Rl및 R2는 수소, 알킬, 시클로알킬, 알케닐, 알키닐, 아르알킬, 아릴, 헤데로시클릭 기 및 이들 헤테로시클릭 기로 치환된 알킬 기 중에서 독립적으로 선택되는 기이고(상기 헤테로시클릭 기는 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바펜넴 환 중에서 선택되는 것임); R3는 알킬, 알케닐, 알키닐, 아르알킬, 헤테로시클릭 기, 이들 헤테로시클릭 기로 치환된 알킬, 및 피롤리디닐메틸 기 중에서 선택되는 기이고(상기 헤테로시클릭 기는 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바페넴 환 중에서 선택되는 기임)];[Wherein R 1 and R 2 are independently selected from hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, aryl, heterocyclic groups and alkyl groups substituted with these heterocyclic groups ( The heterocyclic group is selected from pyranosyl, furanosyl, piperidinyl, pyrrolidinyl, azetidinone ring, cefem ring, penem ring and carbapenem ring; R 3 is a group selected from alkyl, alkenyl, alkynyl, aralkyl, heterocyclic groups, alkyl substituted with these heterocyclic groups, and pyrrolidinylmethyl groups (the heterocyclic groups being pyranosyl, furanosyl , Piperidinyl, pyrrolidinyl, azetidinone ring, cefem ring, penem ring and carbapenem ring);

R3OH (II)R 3 OH (II)

(여기에서, R3는 상기에서 정의된 바와 같다);Wherein R 3 is as defined above;

R4OOC-NHSO2NR1R2(III)R 4 OOC-NHSO 2 NR 1 R 2 (III)

(여기에서, Rl및 R2는 상기에서 정의된 바와 같고, R4는 카르복시 보호 기이다). Wherein R 1 and R 2 are as defined above and R 4 is a carboxy protecting group.

본 발명의 다른 실시형태에 있어서는, -COOR4를 제거하는 단계를 더욱 포 함하여 이루어진다.In another embodiment of the present invention, the method further comprises removing -COOR 4 .

따라서, 여기에 기술된 본 발명은Thus, the present invention described herein

(1) 종래의 방법에서는 4 내지 5단계를 필요로하는 술파미드의 제조방법을, 온화하고 중성인 조건하에 수행할 수 있는, 축합 및 탈보호 양반응의 두 단계로 이루어지는 제조방법을 제공하고;(1) The conventional method provides a production method comprising two steps of condensation and deprotection reactions, in which a method for preparing sulfamide, which requires 4 to 5 steps, can be carried out under mild and neutral conditions;

(2) 항균제, 해열제, 진통제, 감미료, 수면제 및 항경련제와 같은 생리학적으로 활성인 물질을 합성 하기 위한 간편한 방법을 제공하며,(2) provides a convenient way to synthesize physiologically active substances such as antibacterial agents, antipyretics, analgesics, sweeteners, sleeping pills and anticonvulsants,

(3) 상기한 술파미드를 고수율로 제조하는 방법을 제공하는 잇점을 부여할 수 있다.(3) The advantage which provides the method of manufacturing said sulfamide in high yield can be provided.

본 발명의 이들 잇점과 기타의 잇점에 대해서 이 기술분야에서 통상의 지식을 가진 사람이면 다음에 기술하는 상세한 설명을 읽고 이해함으로써 명확하게 알수 있을 것이다.These and other advantages of the present invention will be apparent to those of ordinary skill in the art upon reading and understanding the following detailed description.

여기에서 사용된 약어의 의미는 다음과 같다 :The meaning of the abbreviations used here is as follows:

Ac : 아세틸Ac: Acetyl

Boc : t-부톡시카르보닐Boc: t-butoxycarbonyl

Bz : 벤젠Bz: Benzene

DCM : 디클로로메탄DCM: dichloromethane

EtOAc : 에틸 아세테이트EtOAc: ethyl acetate

Et : 에틸Et: ethyl

Me : 메틸Me: Methyl

PMB : p-메톡시벤질PMB: p-methoxybenzyl

PNB : p-니트로벤질PNB: p-nitrobenzyl

Ph : 페닐Ph: Phenyl

THF : 테트라히드로푸란THF: tetrahydrofuran

To : 톨루엔To: Toluene

t-Bu : t-부틸t-Bu: t-butyl

본 발명에 따른 술파미드(I)의 제조방법에 있어서는, 알코올(II)과 옥시카르보닐술파미드 화합물(III)을, 3가 인 화합물 및 아조디카르복실산 유도체의 존재하에서 반응시킨다.In the method for producing sulfamide (I) according to the present invention, alcohol (II) and oxycarbonyl sulfamide compound (III) are reacted in the presence of a trivalent phosphorus compound and an azodicarboxylic acid derivative.

본 발명의 방법은 다음 일반공정도로 나타낼 수 있다:The method of the present invention can be represented by the following general flowchart:

상기 식에서, Rl및 R2는 각각, 예를 들면 수소, 알킬, 시클로알킬, 알케닐, 알키닐, 아르알킬, 아릴; 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바페넴 환과 같은 헤테로시클릭 기 및 이들 헤테로시클릭 기로 치환된 알킬기 중에서 독립적으로 선택되는 기이고; R3는 예를 들면, 알킬, 알케닐, 알키닐, 아르알킬; 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바페넴 환과 같은 헤테로시클릭 기 및 이들 헤테로시클릭 기로 치환된 알킬기 중에서 선택되는 기이고; 또한 R3는 피롤리디닐메틸이 바람직하고; R4는 카르복시 보호기이다.Wherein R 1 and R 2 are each, for example, hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, aryl; A group independently selected from heterocyclic groups such as pyranosyl, furanosyl, piperidinyl, pyrrolidinyl, azetidinone rings, cefem rings, penem rings and carbapenem rings and alkyl groups substituted with these heterocyclic groups ; R 3 is, for example, alkyl, alkenyl, alkynyl, aralkyl; A group selected from heterocyclic groups such as pyranosyl, furanosyl, piperidinyl, pyrrolidinyl, azetidinone rings, cefem rings, penem rings and carbapenem rings and alkyl groups substituted with these heterocyclic groups; R 3 is preferably pyrrolidinylmethyl; R 4 is a carboxy protecting group.

이하, 본 발명을 구체적으로 기술한다.Hereinafter, the present invention will be described in detail.

옥시카르보닐술파미드 화합물(III), 3가 인 화합물 및 아조디카르복실산 유도체를 불활성 비양자성 용매중에서 알코올(II)에 가한다. 이 혼합물을, 바람직하기는 -70℃ 내지 +50℃의 온도에서 0.5 내지 20시간 동안 반응하도록 방치하여 옥시카르보닐술파미드 화합물(IV)을 얻는다. 필요시, 얻어진 생성물로부터 R4OOC를 통상의 방법으로 제거하여 술파미드 화합물(I)을 얻는다.Oxycarbonylsulfamide compound (III), trivalent phosphorus compounds and azodicarboxylic acid derivatives are added to alcohol (II) in an inert aprotic solvent. The mixture is allowed to react for 0.5 to 20 hours at a temperature of preferably -70 ° C to + 50 ° C to obtain the oxycarbonylsulfamide compound (IV). If necessary, R 4 OOC is removed from the obtained product by a conventional method to obtain a sulfamide compound (I).

본 발명에서 사용되는 각 성분의 바람직한 범위는 다음과 같다 :The preferred range of each component used in the present invention is as follows:

옥시카르보닐술파미드 화합물(R4OOCNHSO2NR1R2)(I)중의 아미노 치환체 Rl및 R2의 예를 들면, 수소, 알킬, 시클로알킬, 알케닐, 알키닐, 아르알킬, 아릴; 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바페넴 환과 같은 헤테로시클릭 기 및 이들 헤테로시클릭 기로 치환된 알킬(예. 피롤리디닐메틸)이 포함된다. Rl및 R2는 같거나 서로 다른 치환체일 수 있다. 카르복시 보호그룹 R4의 예를 들면 알킬, 알케닐, 알키닐, 아르알킬 및 아릴이 포함되고, 바람직하기는 용이하게 제거될 수 있는 카르보네이트 에스테르 형성기이다.Examples of the amino substituents R l and R 2 in the oxycarbonylsulfamide compound (R 4 OOCNHSO 2 NR 1 R 2 ) (I) include hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, aryl; Heterocyclic groups such as pyranosyl, furanosyl, piperidinyl, pyrrolidinyl, azetidinone rings, cefem rings, penem rings and carbapenem rings and alkyl substituted with these heterocyclic groups (e.g. pyrrolidinylmethyl ) Is included. R 1 and R 2 may be the same or different substituents. Preferably, for example, the carboxy protecting group R 4 contains an alkyl, alkenyl, alkynyl, aralkyl and aryl, is a carbonate ester forming groups that can be readily removed.

여기에서 사용되는 알코올(R3OH)(II)중의 R3기는 탄소함유기로써, 예를들면 알킬, 알케닐, 알키닐, 아르알킬; 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바페넴 환과 같은 헤테로시클릭 기 및 이들 헤테로시클릭 기로 치환된 알킬, 특히 피롤리디닐 메틸이 포함되며, 이들 모든 기는 치환체를 함유할 수 있다. 이러한 치환체는, 알킬, 아실, 아실옥시, 알콕시, 술포닐, 술포닐옥시, 에스테르화된 인산 기 및 할로겐과 같은, 반응을 저해하지 않는 기이다.The R 3 group in the alcohol (R 3 OH) (II) used herein is a carbon containing group, for example alkyl, alkenyl, alkynyl, aralkyl; Heterocyclic groups such as pyranosyl, furanosyl, piperidinyl, pyrrolidinyl, azetidinone rings, cefem rings, penem rings and carbapenem rings and alkyl substituted with these heterocyclic groups, in particular pyrrolidinyl methyl All these groups may contain substituents. Such substituents are groups that do not inhibit the reaction, such as alkyl, acyl, acyloxy, alkoxy, sulfonyl, sulfonyloxy, esterified phosphoric acid groups and halogens.

여기에서 사용되는 알코올의 예로는 1차, 2차, 3차 알코올이 포함되나, 상기한 1차 알코올들이 이들의 높은 반응성 때문에 바람직하다.Examples of alcohols used herein include primary, secondary and tertiary alcohols, but the above-described primary alcohols are preferred because of their high reactivity.

여기에서 사용되는 3가 인 화합물의 예를 들면, 트리에틸포스핀 및 트리부틸포스핀과 같은 트리알킬포스핀; 트리페닐포스핀 및 트리톨일포스핀과 같은 트리아릴포스핀; 및 메틸포스파이트, 에틸포스파이트 및 페닐 포스파이트와 같온 포스파이트류가 포함된다.Examples of the trivalent phosphorus compound used herein include trialkylphosphines such as triethylphosphine and tributylphosphine; Triarylphosphines such as triphenylphosphine and tritolylphosphine; And phosphites such as methyl phosphite, ethyl phosphite and phenyl phosphite.

여기에서 사용되는 아조디카르복실산 유도체의 예를 들면, 메틸아조디카르복실레이트, 에틸 아조디카르복실레이트 및 이소프로필 아조디카르복실레이트와 같은 알킬 아조디카르복실레이트류; 아조디니트릴; 아조디카르복스아미드; 아조디카르복실산의 비스디메틸아미드 및 아조디카르복실산의 비스디에틸아미드와 같은 아조디카르복실산의 비스디알킬아미드류; 1,1′-(아조디카르보닐)디피를리딘 및 1,1′-(아조디카르보닐)디퍼페리딘과 같은 1,1′-(아조디카르보닐)디 알킬렌아민류가 포함된다.Examples of azodicarboxylic acid derivatives used herein include alkyl azodicarboxylates such as methyl azodicarboxylate, ethyl azodicarboxylate and isopropyl azodicarboxylate; Azodinitrile; Azodicarboxamides; Bisdialkylamides of azodicarboxylic acids such as bisdimethylamide of azodicarboxylic acid and bisdiethylamide of azodicarboxylic acid; 1,1 ′-(azodicarbonyl) dialkyleneamines such as 1,1 ′-(azodicarbonyl) dipyridine and 1,1 ′-(azodicarbonyl) diperridine.

상기한 각 화합물들에 있어서의 알킬 잔기는 직쇄, 측쇄 또는 시클릭알킬이며, 전형적으로 탄소원자 1 내지 12개를 갖는 알킬 기이다. 상기한 시클릭 알킬은, 그 환 구조내에 산소, 질소 및 황과 같은 하나 이상의 헤테로 원자를 함유할 수 있다. 상기한 알킬 잔기의 예를 들면, 메틸, 에틸, 프로필, 이소프로필, 시클로프로틸, 부틸, 이소부틸, 3차 부틸, 시클로부틸, 시클로프로필메틸, 피롤리디 닐, 펜필, 이소펜틸, 네오펜틸, 시클로펜틸, 시클로프로필에틸, 피폐리딜, 헥실, 시클로헥실, 시클로펜틸메틸, 헵틸, 시클로헵틸, 시클로펜틸에틸, 시클로헥실메틸, 옥틸, 시클로옥틸, 시클로헥실에틸, 노닐 및 도데실이 포함되며, 이들 모든 기는 후술하는 치환체를 함유할 수 있다.The alkyl moiety in each of the above compounds is straight chain, branched or cyclicalkyl and is typically an alkyl group having 1 to 12 carbon atoms. Said cyclic alkyl may contain one or more hetero atoms such as oxygen, nitrogen and sulfur in its ring structure. Examples of the above alkyl moieties include methyl, ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, tertiary butyl, cyclobutyl, cyclopropylmethyl, pyrrolidinyl, pentyl, isopentyl, neopentyl , Cyclopentyl, cyclopropylethyl, piperididyl, hexyl, cyclohexyl, cyclopentylmethyl, heptyl, cycloheptyl, cyclopentylethyl, cyclohexylmethyl, octyl, cyclooctyl, cyclohexylethyl, nonyl and dodecyl, All these groups may contain a substituent described later.

상기한 각 화합물들에 있어서의 알케닐 잔기 또는 알키닐 잔기는 그 분자내에 하나 이상의 불포화 결합을 갖고, 후술하는 치환체를 함유할 수 있는, 알킬 잔기이다.The alkenyl residue or alkynyl residue in each of the compounds described above is an alkyl residue, which has one or more unsaturated bonds in its molecule and may contain substituents described below.

상기한 각 화합물들에 있어서의 아르알킬 잔기는 알킬 잔기 및 아릴 잔기의 결합구조를 갖는 것으로, 전형적으로 탄소원자 7 내지 14개를 갖는 아르알킬 기이다. 이의 예로는 벤질, 펜에틸, 페닐프로필, 페닐이소프로필, 디페닐메틸, 메톡시 디페닐메틸, 나프틸메틸, 푸릴메틸, 티에닐프로필, 옥사졸일메틸, 티아졸일메틸, 이미다졸일메틸, 트리아졸일메틸, 피리딜메틸, 인돌일메틸, 벤조이미다졸일에 틸, 벤조티아졸일메틸 및 퀴놀일메틸이 포함되며, 이들 모든 기는 후술하는 치환체를 함유할 수 있다.The aralkyl moiety in each of the aforementioned compounds has a bonding structure of an alkyl moiety and an aryl moiety, and is typically an aralkyl group having 7 to 14 carbon atoms. Examples thereof include benzyl, phenethyl, phenylpropyl, phenylisopropyl, diphenylmethyl, methoxy diphenylmethyl, naphthylmethyl, furylmethyl, thienylpropyl, oxazolylmethyl, thiazolylmethyl, imidazolylmethyl, tria Zolylmethyl, pyridylmethyl, indolylmethyl, benzoimidazolyl ethyl, benzothiazolylmethyl and quinolylmethyl, all of which may contain substituents described below.

상기한 각 화합물들에 있어서의 아실 잔기는 직쇄, 측쇄 또는 시클릭알카노일과 같은, 탄소원자 14개 이하를 갖는 카르복실릭 아실기; 헤테로 원자를 함유할 수 있는 모노-시클릭 또는 비시클릭 아로일, 아르알카노일 및 아릴알케노일 기; 알킬술포닐, 아릴술포닐과 같은 탄소원자 14개 이하를 갖는 술포닉 아실기; 알콕시카르보닐, 아르알콕시카르보닐 및 카르바모일과 같은 탄소원자 14개 이하를 갖는 카르보닉 아실기; 페닐포스포릴과 같은 탄소원자 14개 이하를 갖는 포스포릭 아실기; 및 술푸릭 아실기(예. 술포)가 포함된다. 상기한 아실 잔기는 후술하는 치환체를 함유할 수 있다.The acyl moiety in each of the above-mentioned compounds may be a carboxylic acyl group having 14 or less carbon atoms, such as straight chain, branched chain or cyclic alkanoyl; Mono-cyclic or bicyclic aroyl, aralkanoyl and arylalkenoyl groups which may contain hetero atoms; Sulfonic acyl groups having up to 14 carbon atoms such as alkylsulfonyl and arylsulfonyl; Carbonic acyl groups having up to 14 carbon atoms such as alkoxycarbonyl, aralkoxycarbonyl and carbamoyl; Phosphoric acyl groups having up to 14 carbon atoms such as phenylphosphoryl; And sulfuric acyl groups (eg sulfo). Said acyl residue may contain the substituent mentioned later.

상기한 각 기들이 치환체를 함유하는 경우, 상기한 탄소수는 치환체내의 탄소수를 포함하지는 않는다.When each of the above groups contains a substituent, the above carbon number does not include the carbon number in the substituent.

상기한 각 기들에 결합할 수 있는 치환체의 예를 들면 직쇄, 측쇄 또는 시클릭 알킬, 알케닐, 알키닐, 아르알킬, 아릴, 카르복실릭 아실, 카르바모일, 보호된 카르복시 및 시아노와 같은 탄소원자 10개 이하를 갖는 탄소 작용성 기; 아미노, 아실아미노, 구아니딜, 우레이도, 알킬아미노, 디알킬아미노, 이소티오시아노, 이소시아노, 니트로 및 니트로소와 같은 질소 작용성 기; 알콕시, 아릴옥시, 시아네이토, 옥소, 카르복실릭 아실옥시, 술포닉 아실옥시 및 포스포릭 아실옥시와 같은 산소작용성 기; 알킬티오, 알킬술포닐, 아릴티오, 아릴술포닐, 아실티오, 티옥소, 술포 및 술파모일과 같은 황 작용성 기; 불소, 염소, 브롬 및 요드와 같은 할로겐; 트리알킬실릴 및 디알킬알콕시실릴과 같은 실릴기; 및 트리알킬스탄일과 같은 스탄일 기가 포함된다.Examples of substituents capable of bonding to each of the foregoing groups include, for example, straight chain, branched or cyclic alkyl, alkenyl, alkynyl, aralkyl, aryl, carboxylic acyl, carbamoyl, protected carboxy and cyano Carbon functional groups having up to 10 atoms; Nitrogen functional groups such as amino, acylamino, guanidyl, ureido, alkylamino, dialkylamino, isothiocyano, isocyano, nitro and nitroso; Oxygen functional groups such as alkoxy, aryloxy, cyanato, oxo, carboxylic acyloxy, sulfonic acyloxy and phosphoric acyloxy; Sulfur functional groups such as alkylthio, alkylsulfonyl, arylthio, arylsulfonyl, acylthio, thioxo, sulfo and sulfamoyl; Halogen such as fluorine, chlorine, bromine and iodine; Silyl groups such as trialkylsilyl and dialkylalkoxysilyl; And stanyl groups such as trialkylstanyl.

본 발명의 방법에 의해 술파미드를 제조하기 위한 출발물질로 사용되는 화합물이, 그 분자내에 부반응을 유발할 수 있는 작용성 기를 갖는 경우, 이 작용성 기는 통상의 방법에 의해 보호 시킨 다음, 축합반응을 수행한 후, 통상의 방법으로 탈보호시킬 수 있다.When a compound used as a starting material for preparing sulfamide by the method of the present invention has a functional group capable of causing a side reaction in the molecule, the functional group is protected by a conventional method and then subjected to condensation reaction. After carrying out, it can be deprotected by conventional methods.

본 발명의 바람직한 반응 조건들은 다음과 같다 :Preferred reaction conditions of the present invention are as follows:

상기한 축합 및 탈보호 반응은 일반적으로 -80℃ 내지 +100℃, 바람직하기는 -70℃ 내지 +50℃의 온도에서 10분 내지 25시간 동안, 바람직하기는 0.5 내지 20시간 동안 수행한다. 생성물은, 반응 용액내에서 안정하기 때문에 장시간 동안 방치해도 무방하다.The condensation and deprotection reactions described above are generally carried out at temperatures of -80 ° C to + 100 ° C, preferably -70 ° C to + 50 ° C, for 10 minutes to 25 hours, preferably for 0.5 to 20 hours. Since the product is stable in the reaction solution, it may be left for a long time.

축합반응에서는, 옥시카르보닐술파미드 화합물(I) 1 내지 5당량, 3가 인화합물 1 내지 5당량, 및 아조디카르복실산 유도체 1 내지 5당량을, 알코올(H) 1당량과 반응시키는 것이 바람직하다. 이들 반응에서는 다음과 같은 용매들중 어느 것이나 사용될 수 있다: 펜탄, 헥산, 옥탄, 벤젠, 톨루엔 및 크실렌과 같은 탄화수소류; 디클로로메탄, 클로로포름, 사염화탄소, 디클로로에탄, 트리클로로에탄 및 클로로벤젠과 같은 할로겐화 탄화수소류; 디에틸 에테르, 메틸이소부틸에테르, 디옥산 및 테트라히드로 푸란과 같은 에테르류; 아세톤, 메틸에틸케톤 및 시클로헥사논과 같은 케톤류;에틸 아세테이트,이소부틸 아세테이트 및 메틸 벤조에이트와 같은 에스테르류; 니트로메탄 및 니트로벤젠과 같은 니트로겐화 탄화수소류; 아세트니트릴 및 벤조니트릴과 같은 니트릴류; 포름아미드, 아세트아미드, 디메틸포름아미드, 디메힐아세트아미드 및 헥사메틸포스포트리아미드와 같은 아미드류, 디메틸술폭시드와 같은 술폭시드류; 디에틸아민, 트리에틸아민, 시클로핵실아민, 벤질아민, 피리딘, 피폴린, 콜리딘 및 퀴놀린과 같은 유기염기류;다른 형태의 공업용의 불활성 용매 또는 이들의 혼합물이다.In the condensation reaction, reacting 1 to 5 equivalents of oxycarbonylsulfamide compound (I), 1 to 5 equivalents of trivalent phosphorus compound, and 1 to 5 equivalents of azodicarboxylic acid derivative with 1 equivalent of alcohol (H) desirable. In these reactions, any of the following solvents may be used: hydrocarbons such as pentane, hexane, octane, benzene, toluene and xylene; Halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, dichloroethane, trichloroethane and chlorobenzene; Ethers such as diethyl ether, methylisobutyl ether, dioxane and tetrahydrofuran; Ketones such as acetone, methyl ethyl ketone and cyclohexanone; esters such as ethyl acetate, isobutyl acetate and methyl benzoate; Nitrated hydrocarbons such as nitromethane and nitrobenzene; Nitriles such as acetonitrile and benzonitrile; Amides such as formamide, acetamide, dimethylformamide, dimethylacetamide and hexamethylphosphotriamide, and sulfoxides such as dimethyl sulfoxide; Organic bases such as diethylamine, triethylamine, cyclonuxylamine, benzylamine, pyridine, pipelin, collidine and quinoline; other types of industrial inert solvents or mixtures thereof.

특히, 축합반응에서 사용되는 반응용매로는 테트라히드로푸란, 디옥산, 디클로로메탄 및 에틸아세테이트와 같은 불활성 용매 중에서 선택되는 적어도 1종이 바람직하다. 상기한 모든 반응은 필요에 따라, 무수 조건하에, 불활성 가스를 사용하여, 및/또는 교반하면서 수행할 수 있다.In particular, the reaction solvent used in the condensation reaction is preferably at least one selected from inert solvents such as tetrahydrofuran, dioxane, dichloromethane and ethyl acetate. All of the above reactions can be carried out, if necessary, under anhydrous conditions, using an inert gas, and / or with stirring.

본 목적 생성물은 미반응 물질, 부반응 생성물 및 용매와 같은 불순물을 추출, 증발, 세척, 농축, 침전, 여과, 건조등과 같은 통상적인 방법으로 제거한 후, 흡착, 용출, 증류, 침전, 용착 및 크로마토그래피와 같은 통상의 후처리에 의해 분리시킬 수 있다.The product of interest is to remove impurities such as unreacted substances, side reaction products and solvents by conventional methods such as extraction, evaporation, washing, concentration, precipitation, filtration, drying, etc., followed by adsorption, elution, distillation, precipitation, deposition and chromatography. It can be separated by conventional post-treatment such as photography.

본 발명에 따른 술파미드의 수율은, 1차 알코올을 출발물질로서 사용한 경우, 일반적으로 50 내지 90% 이다. 축합반응에서의 알코올의 반응성은 1차, 2차 및 3차 알코올의 순서로 알코올의 종류에 따라 감소된다.The yield of sulfamide according to the invention is generally from 50 to 90% when primary alcohol is used as starting material. The reactivity of alcohol in the condensation reaction is reduced according to the type of alcohol in the order of primary, secondary and tertiary alcohols.

상술한 바와 같이, 본 발명에 의하면, 온화하고 중성인 조건하에 축합 반응을 진행시키기 위해, 3가 인 화합물 및 아조디카르복실산 유도체의 존재하에서 알코올과 및 옥시카르보닐 술파미드 화합물을, 반응시키는, 신규한 방법에 의해 술파미드류를 제조할 수 있다. 더욱이, 본 발명에서는, 종래의 방법에서는 4 내지 5단계가 요구되는, 술파미드의 합성을, 단지 2단계, 즉, 온화하고 중성인 조건하에서 수행될 수 있는 축합과 탈보호 양반응 단계만으로 실시할 수 있도록 간소화 시켰다. 특히, 1차 알코올을 출발물질로 사용한 경우, 목적하는 술파미드류를 용이하고도 효율적으로, 고수율로 합성할 수 있다.As described above, according to the present invention, in order to proceed the condensation reaction under mild and neutral conditions, an alcohol and an oxycarbonyl sulfamide compound are reacted in the presence of a trivalent phosphorus compound and an azodicarboxylic acid derivative. The sulfamides can be produced by a novel method. Furthermore, in the present invention, the synthesis of sulfamide, which requires 4 to 5 steps in the conventional method, can be carried out in only two steps, namely, condensation and deprotection reaction steps, which can be carried out under mild and neutral conditions. Simplified to help. In particular, when primary alcohol is used as a starting material, the desired sulfamides can be synthesized easily and efficiently in high yield.

본 발명에 따른 방법의 특징은 다음과 같다:The features of the method according to the invention are as follows:

(1) 술파미드류를 알코올로부터 단지 2단계로 유도할 수 있기 때문에, 방법 이 우수하다.(1) Since sulfamides can be derived from alcohol in only two steps, the method is excellent.

(2) 축합반응이 온화하고 중성인 조건하에서 수행된다.(2) The condensation reaction is carried out under mild and neutral conditions.

(3) 알코올이 광학적 활성 중심을 갖는 경우, 생성물의 배열이 출발물질 (예. 알코올)에 대해 반전되는 SN 2 치환반응을 하는, 축합반응이 입체특이적으로 수행된다. 따라서, 이 반응은 입체이성체의 특이형태를 얻는데 적합하다.(3) When the alcohol has an optically active center, condensation reactions are performed stereospecifically, with SN 2 substitution reactions in which the arrangement of the product is reversed with respect to the starting material (eg alcohol). Therefore, this reaction is suitable for obtaining specific forms of stereoisomers.

본 발명의 방법은, 알코올로부터, 특히 1차 알코올로부터 술파미드류를 직접 유도시키는 것을 특징으로 한다. 술파미드류는 각종의 생리학적으로 활성인 물질(C. H. Lee and H. Kohn, J. Org. Chem. 1990, 55 6098), β-락탐항균제(일본국 특허출원 평 3-207972), 해열제, 진통제 (A. Giraldes, R. Nieves, C. Ochoa, C. Vera de Rey, E. Cenarruzabeitia and B. Lasheras, Eur. J. Med. Chem. 1989, 24, 497), 감미료(G. W. Muller and G. E. DuBois, J. Org. Chem. 1980, 54, 4471), 수면제(B. Unterhalt and G. A. Hanewacker, Arch. Pharm. (Weinheim) 1988, 321, 375) 항경련제(C. H. Lee and H. Kohn, J.Pharm. Sci. 1990, 79 716)의 제조에 유용한데, 이는 이들 물질 및 약제가 종종 그들의 화학구조중에 술파미드를 갖기 때문이다. 예를 들면, 하기 참고예 10에서 얻어진 (1R,5S,6S)-6-[(1R)-1-히드록시에틸]-2[(3S,5S)-5-술파미도메틸피롤리딘-3-일]티오-1-메틸카르바-2-페넴-3-카르복실산은 그람-양성균 및 그람-음성균에 대해 강력한 항균작용을 나타내는 신규한 항균제이다. 더욱이, 본 발명에 의해 알코올로부터 술파미드류를 제조하는 방법은 고분자 다가알코올 및 천연알코올 입체이성질체의 화학적 변형에도 사용될 수 있다.The method of the present invention is characterized by directly inducing sulfamides from alcohols, in particular from primary alcohols. Sulphamids are various physiologically active substances (CH Lee and H. Kohn, J. Org. Chem. 1990, 55 6098), β-lactam antibacterial agents (Japanese Patent Application No. Hei 3-207972), antipyretics, analgesics (A. Giraldes, R. Nieves, C. Ochoa, C. Vera de Rey, E. Cenarruzabeitia and B. Lasheras, Eur. J. Med. Chem. 1989, 24, 497), sweeteners (GW Muller and GE DuBois, J. Org. Chem. 1980, 54, 4471), sleeping pills (B. Unterhalt and GA Hanewacker, Arch. Pharm. (Weinheim) 1988, 321, 375) anticonvulsants (CH Lee and H. Kohn, J. Pharm. Sci 1990, 79 716), since these materials and medicaments often have sulfamides in their chemical structure. For example, (1R, 5S, 6S) -6-[(1R) -1-hydroxyethyl] -2 [(3S, 5S) -5-sulfamidomethylpyrrolidine- obtained in Reference Example 10 below 3-yl] thio-1-methylcarba-2-phenem-3-carboxylic acid is a novel antimicrobial agent that exhibits strong antimicrobial activity against Gram-positive bacteria and Gram-negative bacteria. Furthermore, the method for producing sulfamides from alcohols according to the present invention can also be used for chemical modification of polymer polyhydric alcohols and natural alcohol stereoisomers.

[실시예]EXAMPLE

다음에 본 발명의 실시예를 기술한다.Next, examples of the present invention will be described.

[제조 실시예]Production Example

[옥시카르보닐 술파미드 화합물의 합성][Synthesis of oxycarbonyl sulfamide compound]

단계 A : 알코올(R4OH)을 용매에 녹인 용액에 표 1에 나타낸 바와 같은 반응조건하에서 클로로술포닐 이소시아네이트(CISO2NCO)를 적하시켰다. 혼합물을 교반하여 N-클로로술포닐카르바메이트 용액을 얻었다. 이 응액은 다음 단계의 반응에 직접 사용할 수 있다.Step A: To a solution of alcohol (R 4 OH) in a solvent, chlorosulfonyl isocyanate (CISO 2 NCO) was added dropwise under the reaction conditions as shown in Table 1. The mixture was stirred to give an N-chlorosulfonylcarbamate solution. This solution can be used directly for the next step of reaction.

[표 1]TABLE 1

단계 B : N-클로로술포닐카르바메이트 용액에 표 2에 나타낸 바와 같은 반응조건하에서 아민(R1R2NH)을 첨가한 후, 혼합물을 교반하였다. 반응혼합물을 중화시키고 에틸아세테이트로 추출하였다. 추출물을 수세, 건조 그리고 진공하에서 농축시켜 옥시카르보닐술파미드 화합물을 얻었다.Step B: After adding amine (R 1 R 2 NH) to the N-chlorosulfonylcarbamate solution under the reaction conditions as shown in Table 2, the mixture was stirred. The reaction mixture was neutralized and extracted with ethyl acetate. The extract was washed with water, dried and concentrated in vacuo to afford the oxycarbonylsulphamide compound.

[표 2]TABLE 2

얻어진 생성물의 물리적 상수는 다음과 같다.The physical constant of the obtained product is as follows.

[1차 알코올을 사용하는 축합반응][Condensation Reaction Using Primary Alcohol]

[실시예 1]Example 1

[벤질 알코올 또는 티에닐메틸 알코올 사용][Use benzyl alcohol or thienylmethyl alcohol]

알코올(R3OH)을 용매[테트라히드로푸란(THF) 또는 에틸 아세테이트 (EtOAc)]에 녹인 용액에 혼합물을 교반하면서 표 3 및 4에 나타낸 반응조건하에서 트리페닐포스핀(또는 시료번호 5의 경우 트리부틸포스핀), 옥시카르보닐술파미드(OCSD = R4OCONHSO2NH2) 그리고 디메틸 아조디카르복실레이트(DMAD) 또는 디에틸 아조디카르복실레이트(DEAD)를 첨가하였다.Triphenylphosphine (or sample No. 5) under the reaction conditions shown in Tables 3 and 4 while stirring the mixture in a solution of alcohol (R 3 OH) in a solvent [tetrahydrofuran (THF) or ethyl acetate (EtOAc)]. Tributylphosphine), oxycarbonylsulfamide (OCSD = R 4 OCONHSO 2 NH 2 ) and dimethyl azodicarboxylate (DMAD) or diethyl azodicarboxylate (DEAD) were added.

반응 혼합물을 물로 희석시키고 용매로 추출하였다.The reaction mixture was diluted with water and extracted with solvent.

추출물은 건조, 진공하에서 농축시켜 OSCD와 알코올의 축합 생성물인 술파미드를 얻었다. 이러한 형태의 술파미드는 이후“축합된 술파미드”로써 언급한다.The extract was dried and concentrated in vacuo to give sulfamide, a condensation product of OSCD and alcohol. This form of sulfamide is hereinafter referred to as "condensed sulfamide".

시료번호 5를 제조하기 위한 축합반응을 하기에 상세하게 기술한다.The condensation reaction for preparing Sample No. 5 is described in detail below.

103㎕(1밀리몰)의 벤질알코올을 4㎖의 테트라히드로푸란(THF)에 녹인 용액에 294mg(1.5밀리몰)의 옥시카르보닐술파미드(OCSD : R4=t-부틸)을 첨가하였다. 혼합물을 -60℃로 냉각시켰다. 이 혼합물에 294㎕(1.18밀리몰)의 트리부틸포스핀((n-Bu)3P) 및 189㎕(1.2밀리물)의 디에틸 아조디카르복실레이트(DEAD)를 첨가하였다. 혼합물을 실온으로 점차 올리면서 2시간 교반시키고, 실온에서 40분간 교반시켰다. 상기 반응 혼합물을 물과 에틸아세테이트로 희석시켰다. 유기층을 수세, 건조시킨 다음, 진공중에서 용매를 제거하였다. 잔류물을 실리카겔 컬럼 크로마토그래피로 정제하여 무색결정으로 210mg의 축합된 술파미드(수율 : 73%)를 얻었다.To a solution of 103 μl (1 mmol) of benzyl alcohol in 4 mL of tetrahydrofuran (THF) was added 294 mg (1.5 mmol) of oxycarbonylsulfamide (OCSD: R 4 = t-butyl). The mixture was cooled to -60 ° C. To this mixture was added 294 μl (1.18 mmol) tributylphosphine ((n-Bu) 3 P) and 189 μl (1.2 mmol) diethyl azodicarboxylate (DEAD). The mixture was stirred for 2 hours while gradually raising to room temperature and for 40 minutes at room temperature. The reaction mixture was diluted with water and ethyl acetate. The organic layer was washed with water, dried and then the solvent was removed in vacuo. The residue was purified by silica gel column chromatography to give 210 mg of condensed sulfamide (yield: 73%) as colorless crystals.

[표 3]TABLE 3

[표 4]TABLE 4

얻어진 생성물의 물리적 상수는 다음과 같다 :The physical constants of the obtained product are as follows:

얻은 물리적 상수는 시료번호 1에서 얻은 물리적 상수와 동일하다.The obtained physical constants are the same as those obtained in Sample No. 1.

[실시예 2]Example 2

[피롤리딘메탄올 유도체 사용][Use of pyrrolidinemethanol derivative]

피롤리딘메탄올 유도체(R3OH)를 용매[테트라히드로푸란(THF), 벤젠(BZ),에틸 아세테이트(EtOAc)또는 톨루엔(To)]에 녹인 용액에 혼합물을 교반하면서 표5에 나타낸 바와 같은 반응 조건하에서 트리페닐포스핀(PPh3), 디에틸 아조디카르복실레이트(DEAD) 또는 디이소프로필 아조디카르복실레이트(DIPAD), 그리고 옥시카르보닐 술파미드(OCSD-R4OCONHSO2NH2)를 첨가하였다. 반응 혼합물을 진공하에서 농축시켜 축합된 술파미드를 얻었다.Pyrrolidinemethanol derivative (R 3 OH) was dissolved in a solvent [tetrahydrofuran (THF), benzene (BZ), ethyl acetate (EtOAc) or toluene (To)] while stirring the mixture as shown in Table 5 Triphenylphosphine (PPh 3 ), diethyl azodicarboxylate (DEAD) or diisopropyl azodicarboxylate (DIPAD), and oxycarbonyl sulfamide (OCSD-R 4 OCONHSO 2 NH 2 ) under reaction conditions ) Was added. The reaction mixture was concentrated in vacuo to give condensed sulfamide.

[표 5]TABLE 5

얻어진 생성물의 물리적 상수는 다음과 같다 :The physical constants of the obtained product are as follows:

[실시예 3]Example 3

[β-락탐 알코올 또는 디에틸메틸 알코올 사용][using β-lactam alcohol or diethylmethyl alcohol]

알코올(R3OH)을 테트라히드로푸란(THF)에 녹인 용액에 혼합물을 교반하면서 표 6에 나타낸 바와 같은 반응 조건하에서 트리페닐포스핀(PPh3), 디에틸 아조디카르복실레이트(DEAD) 및 옥시카르보닐술파미드(OCSD=t-BuOCONHSO2NR1R2)를 첨가하였다. 반응 혼합물 진공하에서 농축시켜 축합된 술파미드를 얻었다.Triphenylphosphine (PPh 3 ), diethyl azodicarboxylate (DEAD) and under the reaction conditions as shown in Table 6 while stirring the mixture in a solution of alcohol (R 3 OH) in tetrahydrofuran (THF) and Oxycarbonylsulfamide (OCSD = t-BuOCONHSO 2 NR 1 R 2 ) was added. The reaction mixture was concentrated under vacuum to give condensed sulfamide.

[표 6]TABLE 6

얻어진 생성물의 물리적 상수는 다음과 같다 :The physical constants of the obtained product are as follows:

1) R1=R2=H, R3=((1S,5R,6S)-3-p-메톡시벤질옥시카르보닐-1-메틸-6-[(R)-1-트리에틸실릴옥시에틸]-카르바-2-페넴 )-2-일메틸1) R 1 = R 2 = H, R 3 = ((1S, 5R, 6S) -3-p-methoxybenzyloxycarbonyl-1-methyl-6-[(R) -1-triethylsilyloxy Ethyl] -carba-2-phenem) -2-ylmethyl

2) R1=페닐, R2=H, R3=((1S,5R,6S)-3-p-메특시벤질옥시카르보닐-1-메틸-6-[(R)-1-트리에틸실릴옥시에틸]-카르바-2-페넴)-2-일메틸2) R 1 = phenyl, R 2 = H, R 3 = ((1S, 5R, 6S) -3-p-mesoxybenzyloxycarbonyl-1-methyl-6-[(R) -1-triethyl Silyloxyethyl] -carba-2-phenem) -2-ylmethyl

3) R1=(4-디페닐메톡시카르보닐-3-세펨)-7-일, R2= H, R3= 2-티에닐메틸3) R 1 = (4-diphenylmethoxycarbonyl-3-cepem) -7-yl, R 2 = H, R 3 = 2-thienylmethyl

4) R1= R2= H, R3=(4-p-니트로벤질옥시카르보닐-1-옥소-7-(2-티에닐아세트아미도)-3-세펨 )-3-일메틸4) R 1 = R 2 = H, R 3 = (4-p-nitrobenzyloxycarbonyl-1-oxo-7- (2-thienylacetamido) -3-cepem) -3-ylmethyl

물리적 상수는 2-위치의 이중 결합을 3-위치로 이동하기 위하여 산화에 의해 1-옥사이드로 전환한 후 측정하였다. 산화반응조건은 하기 참고예 14에 기술하였다.Physical constants were measured after conversion to 1-oxide by oxidation to move the 2-position double bond to the 3-position. Oxidation reaction conditions are described in Reference Example 14 below.

융점 138-l42℃Melting point 138-l42 ℃

[2차 알코올을 사용하는 축합반응][Condensation Reaction Using Secondary Alcohol]

[실시예 4]Example 4

[피롤리딘을 사용][Using pyrrolidine]

피롤리딘올을 용매[테트라히드로푸란(THF) 또는 에틸 아세테이트(EtOAc)]에 녹인 용액에 혼합물을 교반하면서 표 7 및 8에 나타낸 반응 조건하에서 트리페닐포스핀(PPh3), 디메틸 아조디카르복실레이트(DMAD) 또는 디에틸 아조디카르복실레이트(DEAD), 그리고 옥시카르보닐술파미드(OCSD=R4OCONHSO2NR1R2)를 첨가하였다.Triphenylphosphine (PPh 3 ), dimethyl azodicarboxyl under the reaction conditions shown in Tables 7 and 8 with stirring the mixture in a solution of pyrrolidinol dissolved in a solvent [tetrahydrofuran (THF) or ethyl acetate (EtOAc)] Rate (DMAD) or diethyl azodicarboxylate (DEAD), and oxycarbonylsulfamide (OCSD = R 4 OCONHSO 2 NR 1 R 2 ) were added.

반응혼합물을 진공하에서 축합시켜 출발물질에 대해 반전된 4-배열을 갖는 축합된 술파미드를 얻었다.The reaction mixture was condensed under vacuum to give condensed sulfamide with 4-array inverted to the starting material.

[표 7]TABLE 7

[표 8]TABLE 8

얻어진 생성물의 물리적 상수는 다음과 같다 .The physical constants of the obtained product are as follows.

1) Rl=페닐, R2= H, R3= (2S,4S)-1-(p-메톡시벤질옥시카르보닐)-2메톡시카르보닐롤리딘-4-일, R4=t-부틸1) R l = phenyl, R 2 = H, R 3 = (2S, 4S) -1- (p-methoxybenzyloxycarbonyl) -2methoxycarbonyrrolidin-4-yl, R 4 = t -Butyl

2) R1=R2=H, R3=(2S,4S)-1-p-메톡시벤질옥시카르보닐-2-메톡시 카르보닐피롤리딘-4-일, R4=t-부틸2) R 1 = R 2 = H, R 3 = (2S, 4S) -1-p-methoxybenzyloxycarbonyl-2-methoxy carbonylpyrrolidin-4-yl, R 4 = t-butyl

3) R1=R2=H, R3=(2S,4S)-1-p-메톡시벤질옥시카르보닐-2-메톡시 카르보닐피롤리딘-4-일, R4=p-니트로벤질3) R 1 = R 2 = H, R 3 = (2S, 4S) -1-p-methoxybenzyloxycarbonyl-2-methoxy carbonylpyrrolidin-4-yl, R 4 = p-nitro benzyl

4) R1=R2=H, R3=(2S,4S)-1-p-메톡시벤질옥시카르보닐-2-메톡시 카르보닐피롤리딘-4-일, R4=p-니트로벤질4) R 1 = R 2 = H, R 3 = (2S, 4S) -1-p-methoxybenzyloxycarbonyl-2-methoxy carbonylpyrrolidin-4-yl, R 4 = p-nitro benzyl

[실시예 5]Example 5

[시클로헥산을 사용][Using cyclohexane]

시클로헥산올을 테트라히드로푸란(THF)에 녹인 용액에 혼합물을 교반하면서 표 9에 나타낸 바와 같은 조건하에서 트리페닐포스핀(PPh3), 디에틸 아조디카르복실레이트(DEAD) 및 옥시카르보닐술파미드(OCSD=t-BuOCONHSO2NR1R2)를 첨가하였다. 반응 혼합물을 진공하에서 농축시켜 축합된 술파미드를 얻었다.Triphenylphosphine (PPh 3 ), diethyl azodicarboxylate (DEAD) and oxycarbonylsulfa under the conditions as shown in Table 9 while stirring the mixture in a solution of cyclohexanol in tetrahydrofuran (THF) Mid (OCSD = t-BuOCONHSO 2 NR 1 R 2 ) was added. The reaction mixture was concentrated in vacuo to give condensed sulfamide.

[표 9]TABLE 9

얻어진 생성물의 물리적 상수는 다음과 같다 .The physical constants of the obtained product are as follows.

[참고예][Reference Example]

[참고예 1]Reference Example 1

[CF3COOH에 의한 탈보호][Deprotection by CF 3 COOH]

실시예 1의 시료번호 1로서 얻어진 t-부톡시카르보닐 보호기를 갖는 축합된 술파미드를 얼음 냉각하에서 디클로로메탄(15용량)과 아니솔(15용량)의 혼합용액에 용해시킨 다음, 트리플루오로아세트산(15용량)을 첨가하였다. 혼합물을 50분간 교반시킨 다음, 얼음욕을 제거한 후 1시간 교반시켰다. 반응 혼합물을 농축시키고, 잔류물을 에테르와 석유에테르(1:6)외 혼합용액으로 재결정하여 벤질 술파미드를 얻었다.The condensed sulfamide having t-butoxycarbonyl protecting group obtained as Sample No. 1 of Example 1 was dissolved in a mixed solution of dichloromethane (15 volumes) and anisole (15 volumes) under ice cooling, and then trifluoro Acetic acid (15 volumes) was added. The mixture was stirred for 50 minutes, then the ice bath was removed and stirred for 1 hour. The reaction mixture was concentrated, and the residue was recrystallized from a mixed solution of ether and petroleum ether (1: 6) to obtain benzyl sulfamide.

무색결정 수율 : 90%Colorless crystal yield: 90%

[참고예 2]Reference Example 2

[CF3COOH에 의한 탈보호][Deprotection by CF 3 COOH]

실시예 2의 시료번호 8로서 얻어진 t-부특시카르보닐 보호기를 갖는 축합된 술파미드에 아니솔(3용량) 및 트리플루오로 아세트산(5용량)을 첨가하였다. 혼합물을 실온에서 30분간 교반시키고 진공하에서 농축시켰다. 잔류물을 디클로로메탄으로 재결정하여 (3S,5S)-3-p-메톡시벤질머캅토-5-술파미도메틸-2-피롤리돈을 얻었다.Anisole (3 volumes) and trifluoro acetic acid (5 volumes) were added to the condensed sulfamide having the t-butoxycarbonyl protecting group obtained as sample number 8 of Example 2. The mixture was stirred at rt for 30 min and concentrated in vacuo. The residue was recrystallized from dichloromethane to give (3S, 5S) -3-p-methoxybenzylmercapto-5-sulfamidomethyl-2-pyrrolidone.

무색결정. 수율 : 68%Colorless crystals. Yield: 68%

[참고예 3]Reference Example 3

[CF3COOH에 의한 탈보호][Deprotection by CF 3 COOH]

실시예 3의 시료번호 3으로서 얻어진 t-부톡시카르보닐 및 디페닐메틸 보호기를 갖는 축합된 술파미드를 얼음 냉각하에서 디를로로메탄(6용량)파 아니솔 (6용량)외 혼합용액에 용해시킨 다음, 트리플루오로 아세트산(6용량)을 첨가하였다. 혼합물을 실온에서 90분간 교반시킨 다음, 반응혼합물을 에테르와 석유에테르로 희석시켜 연한 황색분말로서 7-[N-(2-티에닐메틸)술파모일아미노]-3-세펨-4-카르복실산을 분리하여 얻었다. 수율 : 56%.The condensed sulfamide having t-butoxycarbonyl and diphenylmethyl protecting group obtained as sample No. 3 of Example 3 was added to a mixed solution other than dichloromethane (6 vol.) Anisole (6 vol.) Under ice cooling. After dissolving, trifluoro acetic acid (6 volumes) was added. The mixture was stirred at room temperature for 90 minutes, and then the reaction mixture was diluted with ether and petroleum ether to give 7- [N- (2-thienylmethyl) sulfamoylamino] -3-cef-4-carboxylic acid as a pale yellow powder. It was obtained by separating. Yield 56%.

[참고예 4]Reference Example 4

[H2에 의한 탈보호][Deprotection by H 2 ]

실시예 1의 시료번호 2로서 얻어진 p-니트로벤질옥시카르보닐 보호기를 갖는 축합된 술파미드를 테트라히드로푸란(10용량)에 용해시키고, 촉매로서 10% 팔라듐-탄소(0.2중량%)을 첨가하였다. 혼합물을 수소중에서 1시간 교반시켰다. 촉매를 여과시키고, 여과액을 진공하에서 농축시켰다. 잔류물을 에테르와 석유에테르의 혼합물로 재결정하여 참고예 1에서 얻은 물리적 상수와 동일한 물리적 상수를 갖는 벤질술파미드를 얻었다.Condensed sulfamide with p-nitrobenzyloxycarbonyl protecting group obtained as sample number 2 of Example 1 was dissolved in tetrahydrofuran (10 volumes), and 10% palladium-carbon (0.2 wt%) was added as a catalyst. . The mixture was stirred in hydrogen for 1 hour. The catalyst was filtered off and the filtrate was concentrated in vacuo. The residue was recrystallized from a mixture of ether and petroleum ether to obtain benzylsulfamide having the same physical constants as those obtained in Reference Example 1.

무색결정. 수율 : 77%Colorless crystals. Yield: 77%

[참고예 5]Reference Example 5

[H2에 의한 탈보호][Deprotection by H 2 ]

참고예 4와 유사하게, 하기한 참고예 9에서 얻은 p-니트로밴질에스테르를 10% 팔라듐-탄소 존재하에 수소화시켜 7-(2-티에닐아세트아미도)-3-술파미도메틸-3-세펨-4-카르복실산을 얻었다. 수율 : 참고예 9에서 부터 출발하여 전체 20%.Similar to Reference Example 4, the p-nitrovanzyl ester obtained in Reference Example 9 below was hydrogenated in the presence of 10% palladium-carbon to give 7- (2-thienylacetamido) -3-sulfamidomethyl-3- Cefem-4-carboxylic acid was obtained. Yield: 20% total starting from Reference Example 9.

[참고예 6]Reference Example 6

[팔라듐에 의한 탈보호][Deprotection by palladium]

실시예 1의 시료번호 3으로서 얻어진 알릴옥시카르보닐 보호기를 갖는 축합된 술파미드를 벤젠(10용량)에 용해시키고, 트리페닐포스핀(0.3당량), 에틸아세테이트중의 나트륨 2-에틸헥사노에이트(1.5당량) 및 팔라듐 테트라키스트리폐닐포스핀(0.02당량)을 연속적으로 첨가하였다.Condensed sulfamide having an allyloxycarbonyl protecting group obtained as Sample No. 3 of Example 1 was dissolved in benzene (10 vol), triphenylphosphine (0.3 equiv), sodium 2-ethylhexanoate in ethyl acetate (1.5 equiv) and palladium tetrakistrifenylphosphine (0.02 equiv) were added sequentially.

혼합물을 실온에서 30분간 교반시킨 다음, 반응혼합물을 에틸아세테이트로 희석시키고, 수세하며, 건조시키고 진공하에서 농축시켰다. 잔류물을 톨루엔으로 재결정하여 참고예 1에서 얻은 물리적 상수와 동일한 물리적 상수를 갖는 벤질술파미드를 얻었다. 연한 황색 결정. 수율 : 64%.The mixture was stirred at rt for 30 min, then the reaction mixture was diluted with ethyl acetate, washed with water, dried and concentrated in vacuo. The residue was recrystallized with toluene to obtain benzylsulphamide having the same physical constant as that obtained in Reference Example 1. Light yellow crystals. Yield 64%.

[참고예 7]Reference Example 7

[AlCl3에 의한 탈보호][Deprotection by AlCl 3 ]

염화 알루미늄(6당량)을 -55℃에서 디클로로메탄(15용량)과 아니솔 (15용량)외 혼합용액에 녹인 용액에 디클로로메탄(7.5용량)에 하기한 참고예 13에서 얻은 p-메톡시벤질에스테르를 녹인 용액을 첨가하였다. 혼합물을 25분간 교반시킨 후, 반응혼합물을 물(21용량)에 아세트산 나트륨(18당량)을 녹인 용액에 넣었다. 수층을 취하고, 디클로로메탄으로 세정하고, 탈염하고, 농축시켜 (1S,5R,6S)-6-[(R)-1-히드록시에틸]-2-술파미도메틸-1-메틸카르바-2-페넴-3-카르복실산을 흰색 포옴으로서 얻었다. 수율 : 32%.P-methoxybenzyl obtained in Reference Example 13 described below in dichloromethane (7.5 volumes) in a solution of aluminum chloride (6 equivalents) dissolved in a mixed solution of dichloromethane (15 volumes) and anisole (15 volumes) at -55 ° C. A solution of the ester was added. After the mixture was stirred for 25 minutes, the reaction mixture was added to a solution of sodium acetate (18 equivalents) in water (21 volumes). The aqueous layer was taken, washed with dichloromethane, desalted and concentrated to give (1S, 5R, 6S) -6-[(R) -1-hydroxyethyl] -2-sulfamidomethyl-1-methylcarba- 2-phenem-3-carboxylic acid was obtained as a white foam. Yield 32%.

[참고예 8]Reference Example 8

[AlCl3에 의한 탈보호][Deprotection by AlCl 3 ]

참고예 7과 유사하게, 하기한 참고예 12에서 얻은 p-메톡시벤질 에스테르를 아니솔과 디클로로메탄의 혼합용액 중에서 염화알루미늄으로 탈보호하여 (1S,5R,6S)-6-[(R)-1-히드록시에틸]-2-(페닐술파모일아미노) 메틸-1-메틸카르바-2-폐넴-3-카르복실산을 얻었다. 수율. 22%.Similarly to Reference Example 7, the p-methoxybenzyl ester obtained in Reference Example 12 below was deprotected with aluminum chloride in a mixed solution of anisole and dichloromethane to give (1S, 5R, 6S) -6-[(R) -1-hydroxyethyl] -2- (phenylsulfamoylamino) methyl-1-methylcarba-2-pentem-3-carboxylic acid was obtained. yield. 22%.

[참고예 9]Reference Example 9

[CF3COOH에 의한 탈보호][Deprotection by CF 3 COOH]

참고예 1과 유사하게, 실시예 3의 시료번호 4로서 얻은 t-부특시카르보닐 보호기틀 갖는 축합된 술파미드를 디플로로메탄과 아니솔의 혼합용액 중에서 황트리플루오로아세트산으로 탈보호하여 7-(2-티에닐아세트아미도)-3-술파미도메틸-3-세펨-4-카르복실산 p-니트로벤질에스테르를 얻었다. 상기 생성물을 참조예 5와 유사한 방법으로 수소화시켜 상응하는 유리산을 얻었다.Similarly to Reference Example 1, the condensed sulfamide having the t-butoxycarbonyl protecting framework obtained as Sample No. 4 of Example 3 was deprotected with sulfur trifluoroacetic acid in a mixed solution of difluoromethane and anisole. 7- (2-thienylacetamido) -3-sulfamidomethyl-3-cepem-4-carboxylic acid p-nitrobenzyl ester was obtained. The product was hydrogenated in a similar manner to Reference Example 5 to obtain the corresponding free acid.

[참고예 10]Reference Example 10

[AlCl3에 의한 탈보호][Deprotection by AlCl 3 ]

참고예 7 및 8과 유사하게, (1S,5R,6S)-6-[(1R)-1-히드록시에틸]-2((3S,5S)-5-(N-술파모일-t-부톡시카르보닐아미노)메틸피롤딘-3-일]티오-1-메틸카르바-2-페넴-3-카르복실산디페닐메틸에스테르를 디클로로메탄과 아니솔의 혼합용액 중에서 염화알루미늄으로 탈보호하여 (1R,5S,6S)-6-[(1R)-1-히드록시에틸]-2-[(3S,5S)-5-술파미도메틸피롤리딘-3-일 ]티오-1-메틸카르바-2-페넴-3-카르복실산을 얻었다.Similar to Reference Examples 7 and 8, (1S, 5R, 6S) -6-[(1R) -1-hydroxyethyl] -2 ((3S, 5S) -5- (N-sulfamoyl-t-part Deoxycarbonylamino) methylpyrrolidin-3-yl] thio-1-methylcarba-2-phenem-3-carboxylic acid diphenylmethyl ester was deprotected with aluminum chloride in a mixed solution of dichloromethane and anisole ( 1R, 5S, 6S) -6-[(1R) -1-hydroxyethyl] -2-[(3S, 5S) -5-sulfamidomethylpyrrolidin-3-yl] thio-1-methylcarr Bar-2-phenem-3-carboxylic acid was obtained.

[참고예 11]Reference Example 11

[NAOMe에 의한 탈보호][Deprotection by NAOMe]

실시예 2의 시료번호 4로서 얻어진 아세틸 보호기틀 갖는 축합된 술파미드를 -35℃에서 톨루엔 중에 용해시킨 다음, 메탄올중 4.92M 나트륨 메톡시드 용액을 첨가하였다. 혼합물을 30분간 교반시킨 다음, 반응 혼합물을 물로 희석시켰다. 수층을 취하고, 염산으로 산성화하며, 에틸 아세테이트로 추출하였다. 추출물을 염수 및 물로 세정하고, 황산나트륨으로 건조시키며, 진공하에서 농축시켰다. 잔류물을 톨루엔과 헥산의 혼합용액으로 재결정하여 (2S,4S)-1-t-부톡시카르보닐-2-(N-술파모일-t-부톡시카르보닐아미노)메틸-4-머캅토피롤리딘을 얻었다.The condensed sulfamide with acetyl protecting framework obtained as sample number 4 of Example 2 was dissolved in toluene at −35 ° C., and then a 4.92 M sodium methoxide solution in methanol was added. The mixture was stirred for 30 minutes and then the reaction mixture was diluted with water. The aqueous layer was taken, acidified with hydrochloric acid and extracted with ethyl acetate. The extract was washed with brine and water, dried over sodium sulfate and concentrated in vacuo. The residue was recrystallized from a mixed solution of toluene and hexane to give (2S, 4S) -1-t-butoxycarbonyl-2- (N-sulfamoyl-t-butoxycarbonylamino) methyl-4-mercaptopyrroli Got Dean.

수율 : 69%, 무색결정.Yield: 69%, colorless crystals.

[참고예 12]Reference Example 12

[HCl에 의한 탈보호][Deprotection by HCl]

실시예 3의 시료번호 2로서 얻어진 트리에틸실릴보호기를 갖는 축합된 술파미드를 아세토니트릴(14용량)중에 용해시킨 다음, 아세트산(7.5당량) 및 농염산(15당량)을 -30℃에서 첨가하였다. 혼합물을 1시간 25분 동안 교반시킨 다음, 반응 혼합물을 수성 중탄산나트륨과 에틸 아세테이트의 혼합물에 넣었다. 유기층을 취하고, 수세하고, 건조시키고, 진공하에서 농축시켜 (1S,5R,6S)-2-(N-페닐술파모일-N-t-부톡시카르보닐아미노)메틸-6-[(R)-1-히드록시에틸]1-1-메틸카르바-2-페넴-3-카르복실산 p-메톡시벤질 에스테르를 얻었다. 흰색 포옴.The condensed sulfamide with triethylsilyl protecting group obtained as Sample No. 2 of Example 3 was dissolved in acetonitrile (14 volumes), and then acetic acid (7.5 equivalents) and concentrated hydrochloric acid (15 equivalents) were added at -30 ° C. . The mixture was stirred for 1 hour 25 minutes and then the reaction mixture was placed in a mixture of aqueous sodium bicarbonate and ethyl acetate. The organic layer is taken, washed with water, dried and concentrated in vacuo to give (1S, 5R, 6S) -2- (N-phenylsulfamoyl-Nt-butoxycarbonylamino) methyl-6-[(R) -1- Hydroxyethyl] 1-1-methylcarba-2-phenem-3-carboxylic acid p-methoxybenzyl ester was obtained. White foam.

수율 : 74%.Yield 74%.

[참고예 13]Reference Example 13

[HCl에 의한 탈보호][Deprotection by HCl]

참고예 12와 유사하게, 아세트니트릴 중에 실시예 3의 시료번호 1로서 얻어진 트리에틸실릴 보호기를 갖는 축합된 술파미드를 아세트산과 농염산으로 탈실릴화하여 (1S,5R,6S)-2-(N-술파모일-t-부톡시카르보닐아미노)메틸-6-[(R)-히드록시에틸]-1-메틸카르바-2-페넴-3-카르복실산 p-메톡시벤질에스테르를 흰색 포옴으로 얻었다. 수율 : 79%.Similar to Reference Example 12, the condensed sulfamide having the triethylsilyl protecting group obtained as Sample No. 1 of Example 3 in acetonitrile was desilylated with acetic acid and concentrated hydrochloric acid to give (1S, 5R, 6S) -2- ( N-sulfamoyl-t-butoxycarbonylamino) methyl-6-[(R) -hydroxyethyl] -1-methylcarba-2-phenem-3-carboxylic acid p-methoxybenzylester white Obtained in foam. Yield: 79%.

[참고예 14]Reference Example 14

[m-CPBA에 의한 탈보호][deprotection by m-CPBA]

2-위치에 이중 결합을 갖는 실시예 3의 시료번호 4로서 얻어진 생성물을 얼음 냉각하에서 디클로로메탄(15용량)과 메탄올(3용량)의 혼합용액에 용해시키고, 80% m-클로로-퍼벤조산(1.5당량)을 첨가하였다. 혼합물을 30분간 교란시킨 다음, 반응 혼합물을 디메틸술피드와 에틸아세테이트로 희석시키고, 수성 중탄산나트륨과 물로 세정하고, 건조시키며, 진공하에서 농축시켜 7-(2-티에닐아세트아미도)-3-(N-술파모일-t-부톡시카르보닐아미노)메틸-3-세펨-4-카르복실산 p-니트로벤질에스테르-1-옥사이드를 흰색분말로서 얻었다. 수율 : 23%. 생성물의 물리적 상수는 실시예 3의 시료번호 4에서 얻은 생성물의 물리적 상수와 동일하였다.The product obtained as Sample No. 4 of Example 3 having a double bond in 2-position was dissolved in a mixed solution of dichloromethane (15 volumes) and methanol (3 volumes) under ice cooling, and 80% m-chloro-perbenzoic acid ( 1.5 equiv) was added. The mixture was disturbed for 30 minutes, then the reaction mixture was diluted with dimethylsulfide and ethyl acetate, washed with aqueous sodium bicarbonate and water, dried and concentrated in vacuo to 7- (2-thienylacetamido) -3- (N-Sulfamoyl-t-butoxycarbonylamino) methyl-3-cepem-4-carboxylic acid p-nitrobenzyl ester-1-oxide was obtained as a white powder. Yield 23%. The physical constant of the product was the same as the physical constant of the product obtained in Sample No. 4 of Example 3.

[참고예 15]Reference Example 15

[AcCl-KI에 의한 환원][Reduction by AcCl-KI]

참고예 14에서 얻은 산화물을 아세톤(12용량)에 녹인 용액에 요드화칼륨(10당량)과 염화 아세틸(6당량)을 -35℃에서 첨가하였다. 혼합물을 50분간 교반시킨 다음, 반응 혼합물을 수성 중탄산나트륨과 물로 세정하고, 진공하에서 농축시켜 7-(2-티에닐아세트아미도)-3-(N-술파모일-t-부톡시카르보닐아미노)메틸-3-세펨-4-카르복실산 p-니트로벤질에스테르를 흰색분말로서 얻었다. 수율 : 55%.Potassium iodide (10 equivalents) and acetyl chloride (6 equivalents) were added to a solution of the oxide obtained in Reference Example 14 in acetone (12 volumes) at -35 ° C. The mixture was stirred for 50 minutes, then the reaction mixture was washed with aqueous sodium bicarbonate and water and concentrated in vacuo to give 7- (2-thienylacetamido) -3- (N-sulfamoyl-t-butoxycarbonylamino ) Methyl-3-cepem-4-carboxylic acid p-nitrobenzyl ester was obtained as a white powder. Yield 55%.

다양한 다른 변형이 이 기술분야에서 통상의 지식을 가진 사람에게는 자명할 수 있으며 본 발명의 범주를 벗어남이 없이 이러한 변형을 용이하게 수행할 수 있을 것이다. 따라서, 여기에 첨부된 특허청구의 범위는 여기에 기술된 설명으로 한정되는 것이 아니므로, 본 청구범위는 광범위하게 해석되어져야 한다.Various other modifications will be apparent to those of ordinary skill in the art and will readily be able to make these modifications without departing from the scope of the present invention. Accordingly, the claims appended hereto are not intended to be limited to the description set forth herein, so that the claims should be construed broadly.

Claims (2)

하기 구조식 (III)으로 표시되는 옥시카르보닐술파미드 화합물과 하기 구조식 (II)로 표시되는 알코올을, 아조디카르복실산 유도체와 3가 인 화합물(trivalent phosphorus compound)의 존재하에서 반응시키는 단계를 포함하여 이루어지는 하기 일반식 (I)로 표시되는 술파미드의 제조방법.Reacting the oxycarbonylsulfamide compound represented by the following structural formula (III) with the alcohol represented by the following structural formula (II) in the presence of an azodicarboxylic acid derivative and a trivalent phosphorus compound. The manufacturing method of the sulfamide shown by following General formula (I) formed by. R3NHSO2NR1R2(I)R 3 NHSO 2 NR 1 R 2 (I) (단, 상기 식 중 R1및 R2는 각각 수소, 알킬, 시클로알킬, 알케닐, 알키닐, 아르알킬, 아릴, 헤테로시클릭기 및 헤테로시클릭기로 치환된 알킬로 구성되는 그룹에서 독립적으로 선택되는 기로서, 상기 헤테로시클릭기는 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바페넴 환으로 구성되는 그룹에서 선택되는 것이고; R3는 알킬, 알케닐, 알키닐, 아르알킬, 헤테로시클릭기, 혜테로시클릭기로 치환된 알킬 및 피롤리디닐-메틸로 구성되는 그룹에서 선택되는 기로서, 상기 헤테로시클릭기는 피라노실, 푸라노실, 피페리디닐, 피롤리디닐, 아제티디논 환, 세펨 환, 페넴 환 및 카르바페넴 환으로 구성되는 그룹에서 선택되는 것임);Provided that R 1 and R 2 are each independently selected from the group consisting of alkyl substituted with hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, aryl, heterocyclic group and heterocyclic group Wherein the heterocyclic group is selected from the group consisting of pyranosyl, furanosyl, piperidinyl, pyrrolidinyl, azetidinone rings, cefem rings, penem rings and carbapenem rings; R 3 Is a group selected from the group consisting of alkyl, alkenyl, alkynyl, aralkyl, heterocyclic group, alkyl substituted with a heterocyclic group and pyrrolidinyl-methyl, wherein the heterocyclic group is pyranosyl, fura Nosyl, piperidinyl, pyrrolidinyl, azetidinone rings, cefem rings, penem rings and carbapenem rings); R3OH (II)R 3 OH (II) (단, 상기 식 중 R3는 상기에서 정의한 바와 같음);Wherein R 3 is as defined above; R4OOC-NHSO2NR1R2(III)R 4 OOC-NHSO 2 NR 1 R 2 (III) (단, 상기 식 중 R1및 R2는 상기에서 정의된 바와 같고, R4는 카르복시 보호기임).Wherein R 1 and R 2 are as defined above and R 4 is a carboxy protecting group. 제1항에 있어서, -COOR4기를 제거하는 단계를 더욱 포함하는 것을 특징으로 하는 술파미드의 제조방법.The method of claim 1, further comprising removing the -COOR 4 group.
KR1019930002367A 1992-02-21 1993-02-20 A production method for sulfamide KR100271907B1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP3536692 1992-02-21
JP92-35366 1992-02-21
JP18093092 1992-07-08
JP92-180930 1992-07-08
JP4221767A JP2542773B2 (en) 1991-08-20 1992-08-20 Pyrrolidyl thiocarbapenem derivative
JP92-221767 1992-08-20

Publications (2)

Publication Number Publication Date
KR930017872A KR930017872A (en) 1993-09-20
KR100271907B1 true KR100271907B1 (en) 2000-11-15

Family

ID=27287138

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930002367A KR100271907B1 (en) 1992-02-21 1993-02-20 A production method for sulfamide

Country Status (2)

Country Link
JP (1) JP3238512B2 (en)
KR (1) KR100271907B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100305217B1 (en) * 1999-08-03 2001-09-24 김충섭 Sulfonylaminimide and cationic polymerization composit containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100305217B1 (en) * 1999-08-03 2001-09-24 김충섭 Sulfonylaminimide and cationic polymerization composit containing them

Also Published As

Publication number Publication date
KR930017872A (en) 1993-09-20
JP3238512B2 (en) 2001-12-17
JPH0672986A (en) 1994-03-15

Similar Documents

Publication Publication Date Title
EP0182213B1 (en) Carbapenem compounds and production thereof
IE47958B1 (en) 3-substituted-6-substituted-7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid,its preparation and pharamaceutical compositions containing it
EP0557122B1 (en) A production method for sulfamide
US20090088571A1 (en) Synthesis of 6,7-Dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonic acid amides
JPS61275279A (en) Carbapenem compound
JP3479720B2 (en) Method for producing carbapenems
SE458609B (en) 7-ACYL-3-CARBAMOYLOXI-3-METHYL-CEFAM COMPOUNDS, AND PROCEDURES FOR PREPARING THEREOF
EP0368259B1 (en) Carbapenem derivatives
KR100271907B1 (en) A production method for sulfamide
HU192819B (en) Process for preparing antibacterial penemic derivatives
US3920640A (en) Acylamino-cephem-carboxylic acids and process for preparing them
KR101031143B1 (en) Novel Intermediate for Carbapenem Compound for Oral Administration and Process for Producing the Same
JPS61243088A (en) Heterocyclyl-penem compound
EP0430037A2 (en) Process for producing 2-carbon-substituted carbapenem derivatives
KR870000528B1 (en) Process for preparing 3-azidocephalosporins
JP3242677B2 (en) Novel β-lactam compound and method for producing the same
JPWO2004035539A1 (en) Process for producing carbapenems and intermediates used for the production
FR2549835A1 (en) PENEMO CARBOXYLIC ACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC USE, ESPECIALLY AS ANTIBACTERIAL AGENTS
EP0257602A1 (en) (5R,6S,8R)-6-(1-hydroxyethyl)-2-(3R-pyrolidin-2-one-3-yl-)thiopenem-3-carboxylic acid
JPH0931075A (en) Production of carbapenem intermediate
JPH0288578A (en) Production or carbapenem compound
JP2002338572A (en) Method for producing carbapenems
EP0796857A1 (en) 4-thia-1-azabicyclo(3.2.0)heptane-3-imino-2-isopropylidene-7-oxo analogons of beta-lactams, processes for their preparation and the use thereof
JPS6187661A (en) Optically active acyloxyazetidinone and manufacture
JPH06100565A (en) Carbapenem derivative and its salt

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120802

Year of fee payment: 13

EXPY Expiration of term